Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned?
2024-01-01 Colpani, Agnese; De Vito, Andrea; Zauli, Beatrice; Menzaghi, Barbara; Calcagno, Andrea; Celesia, Benedetto Maurizio; Ceccarelli, Manuela; Nunnari, Giuseppe; De Socio, Giuseppe Vittorio; Di Biagio, Antonio; Leoni, Nicola; Angioni, Goffredo; Giambenedetto, Simona Di; D'Ettorre, Gabriella; Babudieri, Sergio; Madeddu, Giordano
TB outpatient care in a high-income, low-incidence country
2024-01-01 Riccardi, N; Monari, C; Antonello, R M; Saderi, L; Occhineri, S; Pontarelli, A; Zucchi, P; Buonsenso, D; Falbo, E; Faverio, P; Aliberti, S; Parrella, R; Falcone, M; Besozzi, G; Calcagno, A; Goletti, D; Gualano, G; Sotgiu, G; Tadolini, M; Codecasa, L
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation
2009-01-01 Bonora, Stefano; E., Nicastri; Calcagno, Andrea; D. G., De Requena; G., D'Ettorre; L., Sarmati; L., Palmisano; V., Vullo; Di Perri, Giovanni; M., Andreoni
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection
2014-01-01 Nozza, S; Bigoloni, A; Calcagno, Andrea; Galli, L; Pignataro, Ar; D'Avolio, Antonio; Carbone, A; Ripa, M; Bonora, Stefano; Lazzarin, A; Castagna, A.
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients
2015-01-01 Baietto, Lorena; D'Avolio, Antonio; Cusato, Jessica; Pace, S; Calcagno, Andrea; Motta, Ilaria; Corcione, Silvia; Di Perri, Giovanni; De Rosa, Francesco Giuseppe
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases
2022-01-01 Trunfio, M.; Richiardi, L.; Alladio, F.; Staffilano, E.; Longo, B.; Venuti, F.; Ghisetti, V.; Burdino, E.; Bonora, S.; Vineis, P.; Di Perri, G.; Calcagno, A.
HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era
2016-01-01 Ballocca, Flavia; Gili, Sebastiano; D'Ascenzo, Fabrizio; Marra, Walter Grosso; Cannillo, Margherita; Calcagno, Andrea; Bonora, Stefano; Flammer, Andreas; Coppola, John; Moretti, Claudio; Gaita, Fiorenzo
Antiretroviral concentrations in the presence and absence of valproic acid
2020-01-01 Calcagno, A; Cusato, J; Ferrara, M; De Nicolò, A; Lazzaro, A; Manca, A; D'Avolio, A; Di Perri, G; Bonora, S
What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
2019-01-01 Joseph, S. B.; Trunfio, M.; Kincer, L. P.; Calcagno, A.; Price, R. W.
HIV-1 Very Low Level Viremia is Associated with Virological Failure in HAART-treated Patients
2015-01-01 Calcagno, Andrea; Motta, Ilaria; Ghisetti, V; Lo Re, Salvatore; Allice, T; Marinaro, Letizia; Milia, Mg; Tettoni, Mc; Trentini, Laura; Orofino, G; Salassa, B; Di Perri, Giovanni; Bonora, Stefano
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotics Supplementation
2020-01-01 Montrucchio, C; De Nicolò, A; D'Ettorre, G; D'Ascenzo, F; Lazzaro, A; Tettoni, M; D'Avolio, A; Bonora, S; Celani, L; Di Perri, G; Calcagno, A
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens
2011-01-01 Gonzalez De Requena, Daniel; Bonora, Stefano; Viganò, O; Calcagno, Andrea; Cometto, C; D'Avolio, Antonio; Baietto, Lorena; Ghisetti, V; Magnani, S; Ferramosca, S; Vitiello, P; Galli, M; Rusconi, S; Di Perri, Giovanni
Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient
2022-01-01 Parietti, M.; Trunfio, M.; Delmonte, S.; Conti, L.; Trentalange, A.; Bonora, S.; Calcagno, A.; Ribero, S.
Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide
2006-01-01 Gonzlez De Requena, D; Calcagno, A; Bonora, S; Ladetto, L; D'Avolio, A; Sciandra, M; Siccardi, M; Bargiacchi, O; Sinicco, A; Di Perri, G
Personalizing HIV Therapeutics in Resource-Limited Rural Communities: Lessons Learned From the Use of New Tools in Africa
2014-01-01 Calcagno, Andrea; Mohammed, Lamorde; D'Avolio, Antonio; Bonora, Stefano
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis
2016-01-01 Trentalange, Alice; Calcagno, Andrea; Ghisetti, Valeria; Atzori, Cristiana; Busolli, Paolo; Bonora, Stefano; Imperiale, Daniele
Impact of pre-therapy viral load on virological response to modern first-line HAART
2013-01-01 Santoro, Mm; Armenia, D; Alteri, C; Flandre, P; Calcagno, Andrea; Santoro, M; Gori, C; Fabeni, L; Bellagamba, R; Borghi, V; Forbici, F; Latini, A; Palamara, G; Libertone, R; Tozzi, V; Boumis, E; Tommasi, C; Pinnetti, C; Ammassari, A; Nicastri, E; Buonomini, A; Svicher, V; Andreoni, M; Narciso, P; Mussini, C; Antinori, A; Ceccherini Silberstein, F; Di Perri, Giovanni; Perno, Cf
A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era
2015-01-01 D'Ascenzo, Fabrizio; Quadri, Giorgio; Cerrato, Enrico; Calcagno, Andrea; Omedè, P; Grosso Marra, W; Abbate, A; Bonora, Stefano; Biondi Zoccai, G; Moretti, C; Gaita, Fiorenzo
A Novel HPLC-MS/MS Method for the Intracellular Quantification of the Active Triphosphate Metabolite of Remdesivir: GS-443902
2025-01-01 Palermiti, Alice; De Nicolo, Amedeo; Antonucci, Miriam; Soloperto, Sara; Billi, Martina; Manca, Alessandra; Cusato, Jessica; Menegatti, Giorgia; Lamorde, Mohammed; Calcagno, Andrea; Waitt, Catriona; D'Avolio, Antonio
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting
2017-01-01 Marinaro, Letizia; Calcagno, Andrea; Ripamonti, Diego; Cenderello, Giovanni; Pirriatore, Veronica; Trentini, Laura; Salassa, Bernardino; Bramato, Caterina; Orofino, Giancarlo; D'Avolio, Antonio; Rizzi, Marco; Di Perri, Giovanni; Rusconi, Stefano; Bonora, Stefano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? | 1-gen-2024 | Colpani, Agnese; De Vito, Andrea; Zauli, Beatrice; Menzaghi, Barbara; Calcagno, Andrea; Celesia, Benedetto Maurizio; Ceccarelli, Manuela; Nunnari, Giuseppe; De Socio, Giuseppe Vittorio; Di Biagio, Antonio; Leoni, Nicola; Angioni, Goffredo; Giambenedetto, Simona Di; D'Ettorre, Gabriella; Babudieri, Sergio; Madeddu, Giordano | |
| TB outpatient care in a high-income, low-incidence country | 1-gen-2024 | Riccardi, N; Monari, C; Antonello, R M; Saderi, L; Occhineri, S; Pontarelli, A; Zucchi, P; Buonsenso, D; Falbo, E; Faverio, P; Aliberti, S; Parrella, R; Falcone, M; Besozzi, G; Calcagno, A; Goletti, D; Gualano, G; Sotgiu, G; Tadolini, M; Codecasa, L | |
| Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation | 1-gen-2009 | Bonora, Stefano; E., Nicastri; Calcagno, Andrea; D. G., De Requena; G., D'Ettorre; L., Sarmati; L., Palmisano; V., Vullo; Di Perri, Giovanni; M., Andreoni | |
| Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection | 1-gen-2014 | Nozza, S; Bigoloni, A; Calcagno, Andrea; Galli, L; Pignataro, Ar; D'Avolio, Antonio; Carbone, A; Ripa, M; Bonora, Stefano; Lazzarin, A; Castagna, A. | |
| Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients | 1-gen-2015 | Baietto, Lorena; D'Avolio, Antonio; Cusato, Jessica; Pace, S; Calcagno, Andrea; Motta, Ilaria; Corcione, Silvia; Di Perri, Giovanni; De Rosa, Francesco Giuseppe | |
| Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases | 1-gen-2022 | Trunfio, M.; Richiardi, L.; Alladio, F.; Staffilano, E.; Longo, B.; Venuti, F.; Ghisetti, V.; Burdino, E.; Bonora, S.; Vineis, P.; Di Perri, G.; Calcagno, A. | |
| HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era | 1-gen-2016 | Ballocca, Flavia; Gili, Sebastiano; D'Ascenzo, Fabrizio; Marra, Walter Grosso; Cannillo, Margherita; Calcagno, Andrea; Bonora, Stefano; Flammer, Andreas; Coppola, John; Moretti, Claudio; Gaita, Fiorenzo | |
| Antiretroviral concentrations in the presence and absence of valproic acid | 1-gen-2020 | Calcagno, A; Cusato, J; Ferrara, M; De Nicolò, A; Lazzaro, A; Manca, A; D'Avolio, A; Di Perri, G; Bonora, S | |
| What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system? | 1-gen-2019 | Joseph, S. B.; Trunfio, M.; Kincer, L. P.; Calcagno, A.; Price, R. W. | |
| HIV-1 Very Low Level Viremia is Associated with Virological Failure in HAART-treated Patients | 1-gen-2015 | Calcagno, Andrea; Motta, Ilaria; Ghisetti, V; Lo Re, Salvatore; Allice, T; Marinaro, Letizia; Milia, Mg; Tettoni, Mc; Trentini, Laura; Orofino, G; Salassa, B; Di Perri, Giovanni; Bonora, Stefano | |
| Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotics Supplementation | 1-gen-2020 | Montrucchio, C; De Nicolò, A; D'Ettorre, G; D'Ascenzo, F; Lazzaro, A; Tettoni, M; D'Avolio, A; Bonora, S; Celani, L; Di Perri, G; Calcagno, A | |
| Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens | 1-gen-2011 | Gonzalez De Requena, Daniel; Bonora, Stefano; Viganò, O; Calcagno, Andrea; Cometto, C; D'Avolio, Antonio; Baietto, Lorena; Ghisetti, V; Magnani, S; Ferramosca, S; Vitiello, P; Galli, M; Rusconi, S; Di Perri, Giovanni | |
| Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient | 1-gen-2022 | Parietti, M.; Trunfio, M.; Delmonte, S.; Conti, L.; Trentalange, A.; Bonora, S.; Calcagno, A.; Ribero, S. | |
| Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide | 1-gen-2006 | Gonzlez De Requena, D; Calcagno, A; Bonora, S; Ladetto, L; D'Avolio, A; Sciandra, M; Siccardi, M; Bargiacchi, O; Sinicco, A; Di Perri, G | |
| Personalizing HIV Therapeutics in Resource-Limited Rural Communities: Lessons Learned From the Use of New Tools in Africa | 1-gen-2014 | Calcagno, Andrea; Mohammed, Lamorde; D'Avolio, Antonio; Bonora, Stefano | |
| Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis | 1-gen-2016 | Trentalange, Alice; Calcagno, Andrea; Ghisetti, Valeria; Atzori, Cristiana; Busolli, Paolo; Bonora, Stefano; Imperiale, Daniele | |
| Impact of pre-therapy viral load on virological response to modern first-line HAART | 1-gen-2013 | Santoro, Mm; Armenia, D; Alteri, C; Flandre, P; Calcagno, Andrea; Santoro, M; Gori, C; Fabeni, L; Bellagamba, R; Borghi, V; Forbici, F; Latini, A; Palamara, G; Libertone, R; Tozzi, V; Boumis, E; Tommasi, C; Pinnetti, C; Ammassari, A; Nicastri, E; Buonomini, A; Svicher, V; Andreoni, M; Narciso, P; Mussini, C; Antinori, A; Ceccherini Silberstein, F; Di Perri, Giovanni; Perno, Cf | |
| A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era | 1-gen-2015 | D'Ascenzo, Fabrizio; Quadri, Giorgio; Cerrato, Enrico; Calcagno, Andrea; Omedè, P; Grosso Marra, W; Abbate, A; Bonora, Stefano; Biondi Zoccai, G; Moretti, C; Gaita, Fiorenzo | |
| A Novel HPLC-MS/MS Method for the Intracellular Quantification of the Active Triphosphate Metabolite of Remdesivir: GS-443902 | 1-gen-2025 | Palermiti, Alice; De Nicolo, Amedeo; Antonucci, Miriam; Soloperto, Sara; Billi, Martina; Manca, Alessandra; Cusato, Jessica; Menegatti, Giorgia; Lamorde, Mohammed; Calcagno, Andrea; Waitt, Catriona; D'Avolio, Antonio | |
| Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting | 1-gen-2017 | Marinaro, Letizia; Calcagno, Andrea; Ripamonti, Diego; Cenderello, Giovanni; Pirriatore, Veronica; Trentini, Laura; Salassa, Bernardino; Bramato, Caterina; Orofino, Giancarlo; D'Avolio, Antonio; Rizzi, Marco; Di Perri, Giovanni; Rusconi, Stefano; Bonora, Stefano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista36128
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa62
- 2020 - 20269869
- 2010 - 201913041
- 2000 - 20097282
- 1990 - 19994152
- 1980 - 19891467
- 1970 - 1979232
- 1962 - 196924
Rivista
- PHYSICS LETTERS. SECTION B771
- JOURNAL OF HIGH ENERGY PHYSICS498
- PHYSICAL REVIEW LETTERS295
- THE EUROPEAN PHYSICAL JOURNAL. C,...284
- PHYSICAL REVIEW D234
- JOURNAL OF HIGH ENERGY PHYSICS183
- PLOS ONE181
- BLOOD169
- INTERNATIONAL JOURNAL OF MOLECULA...164
- NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
- Humans1437
- Female757
- Male607
- Middle Aged459
- Adult415
- Aged406
- COVID-19344
- Italy298
- Animals217
- Treatment Outcome196
Lingua
- eng24734
- ita5288
- fre259
- spa169
- ger58
- rus29
- und26
- por17
- lat15
- grc6
Accesso al fulltext
- no fulltext21417
- reserved7313
- open4961
- restricted2322
- partially open90
- embargoed17
- mixed9